Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$19.26
-1.03%
Mkt Cap $722.82M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$29.00
Range $29.00 – $29.00
Implied Upside
+50.6%
Consensus $29.00 vs current $19.26
NASDAQ·Healthcare·Biotechnology
$19.26
-1.03%
Mkt Cap $722.82M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$29.00
Range $29.00 – $29.00
+50.6%
Consensus $29.00 vs current $19.26